Grace Therapeutics shareholders elect 5 directors, approve executive pay and KPMG auditor at annual meeting

Grace Therapeutics, Inc.

Five director nominees elected: Vimal Kavuru, A. Brian Davis, Prashant Kohli, S. George Kottayil, Edward Neugeboren; votes for ranged 6.29M-6.30M.
Advisory vote on named executive officer compensation passed: 6,178,757 for, 74,002 against, 75,696 abstain, 1,598,490 broker non-votes.
Ratification of KPMG as independent auditor for FY2026 approved: 7,797,832 for, 127,248 against, 1,865 abstain, no broker non-votes.
Approximately 57.32% of outstanding shares (7,926,945 of 13,828,562) were represented at the meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.